Literature DB >> 8709649

Flow cytometric detection of intracellular antigens for immunophenotyping of normal and malignant leukocytes.

K Groeneveld1, J G te Marvelde, M W van den Beemd, H Hooijkaas, J J van Dongen.   

Abstract

Intracellular antigens are of major importance for immunophenotyping of normal leukocytes as well as leukemias and malignant lymphomas. Immunofluorescence microscopic evaluation of cytocentrifuge preparations has remained the preferred technique for detection of intracellular antigens for a long time. Recently, flow cytometric detection of intracellular antigens has been improved by the development of new permeabilization/fixation solutions. We compared four commercially available solutions: FACS Brand Lysing Solution (FACS Brand; Becton Dickinson, San Jose, CA, USA), Fix & Perm cell permeabilization kit (Fix & Perm; An der Grub, Vienna, Austria), OptiLyse B lysing solution (OptiLyse B; Immunotech, Marseille, France), and ORTHO PermeaFix(PermeaFix; Ortho Diagnostic Systems, Raritan, NJ, USA). These solutions were evaluated for the complexity and duration of the intracellular staining procedure, the effects on light scatter patterns, and the staining results for the intracellular antigens terminal deoxynucleotidyl transferase (TdT), cytoplasmic CD3 (CyCD3), myeloperoxidase (MPO), and cytoplasmic immunoglobulin light chains (CylgL). The four methods could easily be introduced in our laboratory and had only minor effect on the light scatter patterns of the tested cell samples. Each of the four tested antigens was detectable with at least one of the four methods. Only the Fix & Perm cell permeabilization kit could be used for reliable detection of all four intracellular antigens. In a large series of 450 BM and PB samples containing various percentages of TdT+ cells, the results of flow cytometric TdT staining with FACS Brand Lysing Solution were highly comparable to the results obtained by immunofluorescence microscopy (P = <0.00001). Our comparative study shows that flow cytometric detection of the intracellular antigens TdT, CyCD3, MPO, and CylgL can now reliably be performed on a routine basis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8709649

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  7 in total

Review 1.  New additions to antibody panels in the characterisation of chronic lymphoproliferative disorders.

Authors:  E Matutes
Journal:  J Clin Pathol       Date:  2002-03       Impact factor: 3.411

2.  A novel, rapid in cell RNA amplification technique for the detection of low copy mRNA transcripts.

Authors:  V Uhlmann; A Rolfs; E Mix; I Silva; J Hully; L Lu; K Lohman; D Howells; S Picton; J J O'Leary
Journal:  Mol Pathol       Date:  1998-06

3.  XLA patients with BTK splice-site mutations produce low levels of wild-type BTK transcripts.

Authors:  Jeroen G Noordzij; Sandra de Bruin-Versteeg; Nico G Hartwig; Corry M R Weemaes; Egbert J A Gerritsen; Eva Bernatowska; Stefaan van Lierde; Ronald de Groot; Jacques J M van Dongen
Journal:  J Clin Immunol       Date:  2002-09       Impact factor: 8.317

4.  Tumor cell and immune cell profiles in primary human glioblastoma: Impact on patient outcome.

Authors:  María González-Tablas Pimenta; Álvaro Otero; Daniel Angel Arandia Guzman; Daniel Pascual-Argente; Laura Ruíz Martín; Pablo Sousa-Casasnovas; Andoni García-Martin; Juan Carlos Roa Montes de Oca; Javier Villaseñor-Ledezma; Luis Torres Carretero; Maria Almeida; Javie Ortiz; Adelaida Nieto; Alberto Orfao; María Dolores Tabernero
Journal:  Brain Pathol       Date:  2021-02-13       Impact factor: 6.508

5.  Molecular characterization of breast cancer CTCs associated with brain metastasis.

Authors:  Debasish Boral; Monika Vishnoi; Haowen N Liu; Wei Yin; Marc L Sprouse; Antonio Scamardo; David S Hong; Tuan Z Tan; Jean P Thiery; Jenny C Chang; Dario Marchetti
Journal:  Nat Commun       Date:  2017-08-04       Impact factor: 14.919

6.  EuroFlow: Resetting leukemia and lymphoma immunophenotyping. Basis for companion diagnostics and personalized medicine.

Authors:  J J M van Dongen; A Orfao
Journal:  Leukemia       Date:  2012-09       Impact factor: 11.528

Review 7.  EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols.

Authors:  T Kalina; J Flores-Montero; V H J van der Velden; M Martin-Ayuso; S Böttcher; M Ritgen; J Almeida; L Lhermitte; V Asnafi; A Mendonça; R de Tute; M Cullen; L Sedek; M B Vidriales; J J Pérez; J G te Marvelde; E Mejstrikova; O Hrusak; T Szczepański; J J M van Dongen; A Orfao
Journal:  Leukemia       Date:  2012-09       Impact factor: 11.528

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.